Role of MAML1 in targeted therapy against the esophageal cancer stem cells

Abstract

Background Esophageal cancer is the sixth-leading cause of cancer-related deaths worldwide. Cancer stem cells (CSCs) are the main reason for tumor relapse in esophageal squamous cell carcinoma (ESCC). The NOTCH pathway is important in preservation of CSCs, therefore it is possible to target such cells by targeting MAML1 as the main component of the NOTCH transcription machinery. Methods In present study we isolated the CD44+ ESCC CSCs and designed a MAML1-targeted therapy to inhibit the NOTCH signaling pathway. CSCs were isolated using magnetic cell sorting utilizing the CD44 cell surface marker. Several stem cell markers were analyzed in the levels of protein and mRNA expression. The isolated CSCs were characterized in vivo in NUDE mice. Biological role of MAML1 was assessed in isolated CD44+ CSCs. A drug resistance assay was also performed to assess the role of MAML1 in CD44+ CSCs with 5FU resistance. Results The CD44+ CSCs had ability to form tumors in NUDE mice. MAML1 silencing caused a significant decrease (p = 0.019) and ectopic expression caused a significant increase in migration of CD44+ CSCs (p = 0.012). Moreover, MAML1 silencing and ectopic expression significantly increased and decreased 5FU resistance, respectively (p < 0.05). MAML1 silencing significantly increased the number of cells in G1 phase (p = 0.008), and its ectopic expression significantly increased the number of CD44+ CSCS in S phase (p = 0.037). Conclusions MAML1 may be utilized for targeted therapy with a low side effect to eliminate the CD44+ CSCs through inhibition of canonical NOTCH pathway in ESCC patients.

Graphene oxide suppresses the growth and malignancy of glioblastoma stem cell-like spheroids via epigenetic mechanisms

“…As a potential cancer therapeutic agent, GO could effectively inhibit the migration and invasion of human breast and prostate cancer cells and mouse melanoma cells [25]. The cancer stem cells were responsible for tumor relapse and treatment resistance, and became the focus of tumor therapy [26,27]. In this study, we demonstrated that GO could inhibit the growth and formation of GSC spheres and reduce their malignant properties by inducing the differentiation of GSCs.…”

Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer

“…The Notch signaling pathway plays an important role in regulating cell differentiation and proliferation during embryogenesis and normal tissue homeostasis, which have also been implicated in tumorigenesis including development of esophageal cancer [ 125 ]. Mastermind like1 (MAML1) is a key transcription coactivator of this pathway, which could promote the aggressiveness of ESCC through an upregulation of the EMT marker TWIST1 and increase the therapy resistance of ESCC stem cells, respectively [ 126 , 127 ]. In addition, Notch signaling is frequently activated in poorly differentiated tumors and drives a CSC phenotype.…”

Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells

“…NOTCH signaling pathway has a pivotal role in various cellular processes such as cell cycle, migration, metabolism, and apoptosis [150,151]. MiR-129-5p is involved in tumor cells drug response via modulation of NOTCH signaling receptor DLK1 [152].…”